-- 
Roche Is Preparing Second Large Dalcetrapib Study, Soriot Says

-- B y   N a o m i   K r e s g e
-- 
2011-10-13T13:05:56Z

-- http://www.bloomberg.com/news/2011-10-13/roche-is-preparing-second-large-dalcetrapib-study-soriot-says.html
Roche Holding AG (ROG)  is preparing a
second large study of dalcetrapib, its drug for so-called good
cholesterol, in patients at risk of a cardiovascular event,
Pascal Soriot, head of the Basel, Switzerland-based drugmakerâ€™s
pharma unit, said in a conference call today.  To contact the editor responsible for this story:
Naomi Kresge at 
 nkresge@bloomberg.net  